Ulcerative Colitis
📧 Sign up to get email alerts when something new happens for Ulcerative Colitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
A clinical trial is evaluating an educational tool to help melanoma patients with pre-existing autoimmune diseases who are candidates for im…
-
CLINICAL_TRIALS research · 2025-11-06Clinical Trial Update: Diet and Stress Management Combined With Advanced Therapy for Crohn's and Ulcerative Colitis [NA]
A Massachusetts General Hospital–sponsored clinical trial is recruiting to evaluate a combination of diet and stress management with advance…
-
FDA approval · 2025-11-04FDA Approved: SULFASALAZINE — Original Application (Rising Pharma Holdings, Inc.)
FDA approved the original ANDA for sulfazalasine (sulfasalazine) manufactured by Rising Pharma Holdings, Inc.
-
CLINICAL_TRIALS research · 2025-11-04Clinical Trial Update: Improving Outcomes and Reducing Disparities for Patients With Inflammatory Bowel Disease Through Epidemiology and Enhanced Disease Management [NA]
A clinical trial update indicates enrollment by invitation for a study focused on epidemiology and enhanced disease management to improve ou…
-
FDA approval · 2025-11-03FDA Approved: USTEKINUMAB — Supplemental Application (Janssen Biotech, Inc.)
The FDA approved a supplemental application for Ustekinumab (Stelara) from Janssen Biotech, Inc., related to regulatory changes to its label…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-10-28FDA Approved: RENFLEXIS — Supplemental Application (Organon LLC)
FDA approved a supplemental application for RENFLEXIS (infliximab) submitted by Organon LLC. The approval updates the product labeling to re…
-
CLINICAL_TRIALS trial_result · 2025-10-24Clinical Trial Update: ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2 [Phase 3]
Phase 3 trial ABTECT-2 evaluating ABX464 for ulcerative colitis has completed.
-
CLINICAL_TRIALS trial_result · 2025-10-24Clinical Trial Update: ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1 [Phase 3]
Phase 3 ABTECT-1 trial evaluating ABX464 for Ulcerative Colitis has completed.
-
CLINICAL_TRIALS research · 2025-10-24Clinical Trial Update: ABTECT - Maintenance [Phase 3]
ABTECT maintenance phase 3 trial for Ulcerative Colitis is active but not recruiting.
-
EMA approval · 2025-10-22EMA Authorised: Amsparity (adalimumab) — Pfizer Europe MA EEIG
EMA authorised Amsparity (adalimumab) from Pfizer Europe MA EEIG. The biosimilar is approved for multiple autoimmune indications including r…
-
EMA approval · 2025-10-21EMA Authorised: Idacio (adalimumab) — Fresenius Kabi Deutschland GmbH
EMA authorised Idacio, a biosimilar of adalimumab, for multiple inflammatory diseases, produced by Fresenius Kabi Deutschland GmbH. The indi…
-
CLINICAL_TRIALS trial_result · 2025-10-20Clinical Trial Update: Association Between Effectiveness of Mirikizumab and UC Patients With High Neutrophilic Infiltration in Epithelium of the Colonic Mucosa [Phase 4]
This Phase 4 trial investigates the association between Mirikizumab effectiveness and ulcerative colitis in patients with high neutrophilic …
-
CLINICAL_TRIALS trial_result · 2025-10-20Clinical Trial Update: Study of Novel Therapeutics for Acute Remedy of Colitis [Phase 2]
This clinical trial update notes a Phase 2 study evaluating novel therapeutics for acute treatment of ulcerative colitis, currently recruiti…
-
FDA approval · 2025-10-17FDA Approved: HADLIMA — Supplemental Application (Organon LLC)
FDA approved a supplemental application for HADLIMA (adalimumab-bwwd) from Organon LLC, supporting expanded indications for this adalimumab …
-
FDA approval · 2025-10-16FDA Approved: XELJANZ — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for XELJANZ (tofacitinib) filed by Pfizer Laboratories Div Pfizer Inc, resulting in changes to t…
-
FDA approval · 2025-10-16FDA Approved: AMJEVITA — Supplemental Application (Nuvaila Limited)
FDA approved a supplemental application for Amjevita (adalimumab-atto) submitted by Nuvaila Limited.
-
CLINICAL_TRIALS trial_result · 2025-10-16Clinical Trial Update: Long-term Safety and Efficacy Study of Adalimumab in Pediatric Subjects With Ulcerative Colitis [Phase 3]
A Phase 3 long-term safety and efficacy study of adalimumab in pediatric patients with ulcerative colitis has completed, with results posted…
-
CLINICAL_TRIALS trial_result · 2025-10-15Clinical Trial Update: To Evaluate Efficacy and Long-term Safety of Ozanimod in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis [Phase 3]
Phase 3 trial evaluating efficacy and long-term safety of Ozanimod in Japanese patients with moderately to severely active ulcerative coliti…
-
CLINICAL_TRIALS trial_result · 2025-10-15Clinical Trial Update: Long-term Safety and Efficacy of Efavaleukin Alfa in Participants With Moderately to Severely Active Ulcerative Colitis [Phase 2]
This clinical trial update reports long-term safety and efficacy data for Efavaleukin Alfa in adults with moderately to severely active Ulce…
-
EMA approval · 2025-10-08EMA Authorised: Humira (adalimumab) — AbbVie Deutschland GmbH & Co. KG
The EMA authorised Humira (adalimumab) by AbbVie Deutschland GmbH & Co. KG for multiple indications including ankylosing spondylitis, juveni…
-
CLINICAL_TRIALS trial_result · 2025-10-07Clinical Trial Update: A Study to Assess Adverse Events and Change in Disease Activity From Intravenous (IV) and Subcutaneous (SC) Lutikizumab in Adult Participants With Active Ulcerative Colitis [Phase 2]
Phase 2 clinical trial update evaluating adverse events and changes in disease activity after intravenous or subcutaneous lutikizumab in adu…
-
CLINICAL_TRIALS trial_result · 2025-10-06Clinical Trial Update: A Study of Vedolizumab SC Given to Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease in South Korea
A South Korea–focused clinical trial update shows Vedolizumab SC is being studied in adults with moderate-to-severe Ulcerative Colitis or Cr…
-
CLINICAL_TRIALS research · 2025-10-03Clinical Trial Update: Acupuncture in Pediatrics and Adolescents With Chronic Inflammatory Bowel Diseases [NA]
Clinical trial update describing an active but not recruiting study at the Medical University of Vienna evaluating acupuncture in children a…
-
CLINICAL_TRIALS research · 2025-10-03Clinical Trial Update: A Study of Efficacy and Safety of Rosnilimab in Subjects With Moderate to Severe Ulcerative Colitis (ROSETTA) [Phase 2]
Phase 2 clinical trial ROSETTA is evaluating the efficacy and safety of Rosnilimab in moderate to severe ulcerative colitis and is currently…
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: CorEvitas Inflammatory Bowel Disease (IBD) Registry
CorEvitas is enrolling by invitation participants in an inflammatory bowel disease (IBD) registry to collect real-world data on IBD.